|
|
Femuroacetabular Mixed Impingement with Anterolateral Chondrolabral Lesion and Periarticular Tenosynovial Giant Cell Tumor in the Right Psoas Compartment
|
Abstract:
Tenosynovial giant cell tumor (TGCT) is a fibrohistiocytic, typically benign tumor deriving from the synovia and hemosiderin deposition. Any joint can be affected and symptoms are unspecific like joint pain, swelling and stiffness. There are different treatment methods, however the standard therapy is early surgical resection. We describe a case, where a 23-year-old patient suffered from a cam-emphasized mixed impingement with a labral tear, and therefore received a hip arthroscopy performing an extracapsular approach. Incidental findings in the MRI showed an unknown periarticular tumor in the right psoas compartment—later identified as TGCT, which was simultaneously resected arthroscopically in toto. Our case report shows, that even relatively big, extraarticular, benign lesions can be resected endoscopically, which offers a great minimal invasive alternative compared to open surgery to minimize postoperative immobilisation and pain.
| [1] | Kager, M., Kager, R., Fałek, P., Fałek, A., Szczypiór, G., Niemunis-Sawicka, J., Rzepecka-Wejs, L., Starosławska, E. and Burdan, F. (2022) Tenosynovial Giant Cell Tumor. Folia Medica Cracoviensia, 62, 93-107. https://doi.org/10.24425/fmc.2022.141702 |
| [2] | Sbaraglia, M., Bellan, E. and Dei Tos, A.P. (2020) The 2020 WHO Classification of Soft Tissue Tumours: News and Perspectives. Pathologica, 113, 70-84. https://doi.org/10.32074/1591-951X-213 |
| [3] | Robert, M., Farese, H. and Miossec, P. (2022) Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis with Neoplastic Features. Frontiers in Immunology, 13, Article 820046. https://doi.org/10.3389/fimmu.2022.820046 |
| [4] | Noailles, T., Brulefert, K., Briand, S., et al. (2017) Giant Cell Tumor of Tendon Sheath: Open Surgery or Arthroscopic Synovectomy? A Systematic Review of the Literature. Orthopaedics & Traumatology: Surgery & Research, 103, 809-814. https://doi.org/10.1016/j.otsr.2017.03.016 |
| [5] | Stacchiotti, S., Dürr, H.R., Schaefer, I.M., et al. (2023) Best Clinical Management of Tenosynovial Giant Cell Tumour (TGCT): A Consensus Paper from the Community of Experts. Cancer Treatment Reviews, 112, Article 102491. https://doi.org/10.1016/j.ctrv.2022.102491 |
| [6] | Chan, A.S., Katiyar, V., Dy, P. and Singh, V. (2023) Updates on the Treatment of Tenosynovial Giant Cell Tumor. Hematology/Oncology and Stem Cell Therapy, 16, 307. https://doi.org/10.56875/2589-0646.1032 |
| [7] | Forster-Horvath, C., Domb, B.G., Ashberg, L. and Herzog, R.F. (2017) A Method for Capsular Management and Avoidance of Iatrogenic Instability: Minimally Invasive Capsulotomy in Hip Arthroscopy. Arthroscopy Techniques, 6, e397-e400. https://doi.org/10.1016/j.eats.2016.10.015 |